Oruka Therapeutics Director Sells $6.2 Million Worth of Shares
Carl Dambkowski, director at Oruka Therapeutics (NASDAQ:ORKA), sold 105,000 shares worth approximately $6.2 million on May 21, 2026, reducing his direct equity stake by nearly 59%. The sale followed the exercise of vested options and was disclosed via an SEC Form 4 filing.
Tickers: $ORKA
Topics: executive activity SEC filing stock sale